August 10, 2022: NIH Pragmatic Trials Collaboratory Announces Grand Rounds Series on Ethical and Regulatory Challenges in Pragmatic Trials

Steven Joffe, MD, MPH
Steven Joffe will give a keynote presentation on September 9.

The NIH Pragmatic Trials Collaboratory is launching a special Grand Rounds series to examine ethical and regulatory challenges in pragmatic clinical trials. Over the past decade, the program’s Ethics and Regulatory Core has worked with investigators to navigate ethical and regulatory complexities associated with research conducted within healthcare systems. With this new Grand Rounds series, the Core is bringing together bioethicists, investigators, and regulatory experts to share lessons learned, discuss empirical findings, and explore remaining uncertainties.

The webinar series, Ethical and Regulatory Dimensions of Pragmatic Clinical Trials, will kick off on Friday, September 9, at 1:00 pm ET with a keynote presentation by Dr. Steven Joffe, chair of the Department of Medical Ethics and Health Policy in the Perelman School of Medicine at the University of Pennsylvania.

The series will include an additional 5 moderated webinar discussions with panels of experts. The sessions will focus on a range of topics, including responding to signals of mental and behavioral health risk in pragmatic trials; the ethics of data sharing; ethical and regulatory considerations in the design and conduct of pragmatic trials; pragmatic research involving patients with dementia; and the use of waivers and alterations of consent.

Download the series flyer and see the full schedule below.

All session are free and open to the public; no registration is required. Recordings will be archived on the Grand Rounds website.

August 10, 2022: PCT Grand Rounds to Highlight Strategies for Including Diverse Participants in Pragmatic Trials

Head shot of Dr. Consuelo WilkinsIn this Friday’s PCT Grand Rounds, Dr. Consuelo Wilkins of Vanderbilt University will present “Equitably Including Diverse Participants in Pragmatic Clinical Trials.” The Grand Rounds session will be held on Friday, August 12, 2022, at 1:00 pm eastern.

Dr. Wilkins is senior vice president and senior associate dean for health equity and inclusive excellence and a professor of medicine at Vanderbilt University Medical Center.

Join the online meeting.

August 3, 2022: Economic Evaluation of Platform Trial Designs Featured in This Week’s PCT Grand Rounds

Head shot of Dr. Jay JH ParkIn this Friday’s PCT Grand Rounds, Dr. Jay JH Park of McMaster University will present “Economic Evaluation of Platform Trial Designs.” The Grand Rounds session will be held on Friday, August 5, 2022, at 1:00 pm eastern.

Dr. Park is director of the Platform Trials Initiative in the Canadian Critical Care Trials Group and an assistant professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University.

Join the online meeting.

July 27, 2022: COVID-19 Grand Rounds to Feature Interferon Therapy Results From TOGETHER Trial

Head shots of Dr. Edward Mills and Dr. Jeffrey GlennIn this Friday’s COVID-19 Grand Rounds, Dr. Edward Mills of McMaster University and Dr. Jeffrey Glenn of Stanford University will present “Effect of Early Treatment With Single-Dose Pegylated Interferon Lambda Among Patients With COVID-19: Results From The TOGETHER Trial.”

The TOGETHER trial is a randomized adaptive platform trial investigating several treatments for COVID-19.

The Grand Rounds session will be held on Friday, July 29, at 1:00 pm eastern. Join the online meeting.

The NIH Pragmatic Trials Collaboratory Coordinating Center is using its popular Grand Rounds platform to share late-breaking research and promote resources in support of clinical researchers affected by the COVID-19 public health emergency. For previous COVID-19 Grand Rounds, and more news and resources related to the COVID-19 public health emergency, see the COVID-19 Resources page.

July 20, 2022: ACTIV-6 Reaches 1 Year, Will Share Results in COVID-19 Grand Rounds

Headshot of Dr. Susanna NaggieIn this Friday’s COVID-19 Grand Rounds, Dr. Susanna Naggie of Duke University will present “ACTIV-6: One Year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone.”

ACTIV-6 is a nationwide, double-blind study evaluating the effectiveness of repurposed medications in reducing symptoms of mild to moderate COVID-19 in outpatients.

The Grand Rounds session will be held on Friday, July 22, at 1:00 pm eastern. Join the online meeting.

The NIH Pragmatic Trials Collaboratory Coordinating Center is using its popular Grand Rounds platform to share late-breaking research and promote resources in support of clinical researchers affected by the COVID-19 public health emergency. For previous COVID-19 Grand Rounds, and more news and resources related to the COVID-19 public health emergency, see the COVID-19 Resources page.

Grand Rounds July 22: ACTIV-6: One Year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone (Susanna Naggie, MD, MHS)

Speaker:

Susanna Naggie, MD, MHS
Professor of Medicine
Vice Dean for Clinical Research
Duke University School of Medicine
Infectious Diseases Research
Duke Clinical Research Institute

 

Topic: ACTIV-6: 1-year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone
Date: Friday, July 22, 2022, 1:00-2:00 p.m. ET

 

Meeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php.

To join the online meeting:
Go to https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6

Click ‘Connect to Audio”
Choose ‘Computer Audio’ or ‘I will call in’.
If using the ‘call in option’, follow the information from the dialog box that appears.
Be certain to use the Access Code AND the Attendee ID.

Troubleshooting:
If the URL above does not work, go to dukemed.webex.com and enter:
Meeting Number: 2622 682 0537
Meeting Password: 12345

For Audio ONLY:
Call-in toll number (US/Canada): 1-650-479-3207
Access code: 2622 682 0537

NOTE: For Toll-free users, the call-back (call me) services are also available.

July 13, 2022: Lessons From the ACTIV Public-Private Partnership to Be Shared in COVID-19 Grand Rounds

Headshot of Dr. Stacey AdamIn this Friday’s COVID-19 Grand Rounds, Dr. Stacey Adam of the Foundation for the NIH will present “Overview of Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Public-Private Partnership and Lessons Learned.”

The NIH announced the ACTIV public-private partnership in April 2020 to develop a coordinated research strategy for speeding development of COVID-19 treatments and vaccines. The partnership is coordinated by the Foundation for the NIH and brings together the Biomedical Advanced Research and Development Authority, the Centers for Disease Control and Prevention, and the US Food and Drug Administration, the Department of Defense, the Department of Veterans Affairs, the Countermeasures Acceleration Group, the European Medicines Agency, and representatives from academia, philanthropic organizations, and biopharmaceutical companies.

The Grand Rounds session will be held on Friday, July 15, at 1:00 pm eastern. Join the online meeting.

The NIH Pragmatic Trials Collaboratory Coordinating Center is using its popular Grand Rounds platform to share late-breaking research and promote resources in support of clinical researchers affected by the COVID-19 public health emergency. For previous COVID-19 Grand Rounds, and more news and resources related to the COVID-19 public health emergency, see the COVID-19 Resources page.

July 6, 2022: Grand Rounds to Spotlight COVID-OUT Trial of Metformin, Ivermectin, and Fluvoxamine

Headshots of Drs. Carolyn Bramante, Thomas Murray, Jared Huling
Left to right: Dr. Carolyn Bramante, Dr. Thomas Murray, Dr. Jared Huling

In this Friday’s COVID-19 Grand Rounds, Dr. Carolyn Bramante, Dr. Thomas Murray, and Dr. Jared Huling of the University of Minnesota will present “Results From the COVID-OUT Trial, a Phase-3 Trial of Outpatient Treatment for COVID-19 Using Metformin, Ivermectin, and Fluvoxamine.”

The Grand Rounds session will be held on Friday, July 8, at 1:00 pm eastern. Join the online meeting.

The NIH Pragmatic Trials Collaboratory Coordinating Center is using its popular Grand Rounds platform to share late-breaking research and promote resources in support of clinical researchers affected by the COVID-19 public health emergency. For previous COVID-19 Grand Rounds, and more news and resources related to the COVID-19 public health emergency, see the COVID-19 Resources page.

June 15, 2022: PCT Grand Rounds to Feature PREPARE Study of a Patient-Centered Asthma Management Strategy

Headshot of Dr. Elliot IsraelIn this Friday’s PCT Grand Rounds, Dr. Elliot Israel of Harvard Medical School will present “PREPARE: A Successful, Primarily Remote Pragmatic Trial in a Black and Latinx Population With Asthma: Challenges and Successes.” The Grand Rounds session will be held on Friday, June 17, 2022, at 1:00 pm eastern.

Dr. Israel is a professor of medicine at Harvard Medical School and director of clinical research in the pulmonary division at Brigham and Women’s Hospital. The PCORI-funded Person Empowered Asthma Relief (PREPARE) study was a pragmatic clinical trial of a patient-centered approach to managing moderate to severe asthma for African-American/Black and Hispanic/Latino adults.

Join the online meeting.

June 8, 2022: PCT Grand Rounds Asks, ‘Do We Really Need So Many Heart Failure Clinicians?’

Headshot of Dr. Tariq AhmadIn this Friday’s PCT Grand Rounds, Dr. Tariq Ahmad of Yale University will present “Do We Really Need So Many Heart Failure Clinicians?” The Grand Rounds session will be held on Friday, June 10, 2022, at 1:00 pm eastern.

Dr. Ahmad is the medical director of heart transplantation and mechanical circulatory support and chief of heart failure in the Yale School of Medicine. His work focuses on the care of patients with end-stage heart failure, left ventricular assist devices, and cardiac transplantation.

Join the online meeting.